|
Nov 3
|
Mednow Restructuring to Meet Long-Term Needs of Stakeholders
|
|
Apr 26
|
Mednow Releases Multiple Updates to Its IOS, Android and Web Based Applications, Including Pharmacist Led In-App Prescribing, Clinical Services Flows, and Single Sign-On for Seamless Patient and Partner Experiences
|
|
Apr 26
|
Mednow Second Quarter 2023 Earnings: CA$0.20 loss per share (vs CA$0.26 loss in 2Q 2022)
|
|
Apr 24
|
IIROC Trading Resumption - MNOW
|
|
Apr 24
|
Mednow Announces Financing by Way of Prospectus Supplement for Proceeds of up to $1,000,000 Led by Gravitas Securities
|
|
Apr 24
|
IIROC Trading Halt - MNOW
|
|
Apr 24
|
Mednow announces PBAS partnership.
|